6-FLUORO-1-(BETA-D-GLUCOPYRANOSYL)-CAMALEXIN
Compound with spectra: 1 NMR
| SpectraBase Compound ID | AV1THw61QnL |
|---|---|
| InChI | InChI=1S/C17H17FN2O5S/c18-8-1-2-9-10(16-19-3-4-26-16)6-20(11(9)5-8)17-15(24)14(23)13(22)12(7-21)25-17/h1-6,12-15,17,21-24H,7H2/t12-,13-,14+,15-,17-/m0/s1 |
| InChIKey | TYVBMXKOEOHTPD-JBXGNFEISA-N |
| Mol Weight | 380.39 g/mol |
| Molecular Formula | C17H17FN2O5S |
| Exact Mass | 380.084221 g/mol |
| Enantiomer InChIKey | TYVBMXKOEOHTPD-OWVAZHOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3CN |
6-METHOXY-1-(BETA-D-GLUCOPYRANOSYL)-CAMALEXIN
3-(2-HYDROXYHEXAFLUOROPROP-2-YL)-1-(BETA-D-GLUCOPYRANOSYL)INDOLE
4,5,6a-triphenyl-3,3a,4,6a-tetrahydrocyclopenta[b]pyrrol-4-ol
Ethyl 7-allylthio-1-benzyl-2-triisopropylsiloxy-1H-indole-3-carboxylate
Diethyl 7-amino-4,5-dihydro-2-methylthio-5-phenylpyrazolo[1,5-a]pyrimidine-3,6-dicarboxylate
2-amino-N-(1,3-benzodioxol-5-ylmethyl)-1-(4-bromophenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide
4-[(3R,4R,5S)-3,4-Dibenzyloxy-5-(tert-butyldiphenylsiloxy)methyl-pyrrolidin-2-ylidene]-2-[(2S)-2,3-epoxy-2-methylpropionyl]-4H-oxazol-5-one
3-methoxy-10-methyl-5-{[(4-methylphenyl)sulfonyl]oxy}-5,10-dihydroindolo[3,2-b]indole
2-(hexylsulfanyl)-6-isopropyl-3-(4-methoxyphenyl)-3,5,6,8-tetrahydro-4H-pyrano[4',3':4,5]thieno[2,3-d]pyrimidin-4-one
PHENYL-(5-ACETAMIDO-3,5-DIDEOXY-D-GLYCERO-ALPHA-D-GALACTO-2-NONULOPYRANOSYL)-(2->3)-BETA-D-GALACTOPYRANOSYL-(1->4)-1-THIO-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Probing the phytopathogenic stem rot fungus with phytoalexins and analogues: unprecedented glucosylation of camalexin and 6-methoxycamalexin | Bioorganic & Medicinal Chemistry | 2002 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.